Want to join the conversation?
$WAT said in the Americas region, the US delivered 2% growth in 1Q16 led by low-teens growth from the US pharmaceutical market. US industrial sales were affected by strong quarterly comparison as well as TA's Discovery system launch. The company expects government and academic sales to ramp later in 2016 as budgets get released.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.